Characterizing optical properties of nano contrast agents by using cross-referencing OCT imaging. by Xi, Jiefeng et al.
Characterizing optical properties of  
nano contrast agents by using cross-referencing 
OCT imaging 
Jiefeng Xi, Yongping Chen, and Xingde Li* 
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205, USA 
*xingde@jhu.edu 
Abstract: We report a cross-referencing method to quickly and accurately 
characterize the optical properties of nanoparticles including the extinction, 
scattering, absorption and backscattering cross sections by using an OCT 
system alone. Among other applications, such a method is particularly 
useful for developing nanoparticle-based OCT imaging contrast agents. The 
method involves comparing two depth-dependent OCT intensity signals 
collected from two samples (with one having and the other not having the 
nanoparticles), to extract the extinction and backscattering coefficient, from 
which the absorption coefficient can be further deduced (with the help of the 
established scattering theories for predicting the ratio of the backscattering 
to total scattering cross section). The method has been experimentally 
validated using test nanoparticles and was then applied to characterizing 
gold nanocages. With the aid of this method, we were able to successfully 
synthesize scattering dominant gold nanocages for the first time and 
demonstrated the highest contrast enhancement ever achieved by the gold 
nanocages (and by any nanoparticles of a similar size and concentration) in 
an in vivo mouse tumor model. This method also enables quantitative 
analysis of contrast enhancement and provides a general guideline on 
choosing the optimal concentration and optical properties for the 
nanoparticle-based OCT contrast agents. 
©2013 Optical Society of America 
OCIS codes: (110.4500) Optical coherence tomography; (170.3880) Medical and biological 
imaging; (290.0290) Scattering; (290.5820) Scattering measurements. 
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1. Introduction 
The imaging contrast of optical coherence tomography (OCT) is determined by the optical 
properties of biological tissue (i.e. scattering and absorption) and is often dominated by 
scattering. Unfortunately, the intrinsic OCT imaging contrast can be very weak in many cases 
for discerning pathological change. As in all clinical imaging modalities, the use of exogenous 
contrast agents have been investigated for improving OCT imaging contrast and potentially 
gaining molecular specificity. An ideal contrast agent is expected to have a small size (i.e. less 
than 100 nm) for effective systemic delivery, and should be strong in backscattering in order 
to reflect more photons towards the detector. In addition, the contrast agents should be 
biocompatible and easy to conjugate for active targeting. Several types of contrast agents, 
such as core-shell microsphere, air-filled micro-bubbles, dyes and structured gold 
nanoparticles, have been developed for improving OCT contrast [1–8]. However, most of 
these contrast agents are either too large or are dominated by absorption (i.e., absorbing the 
imaging photons as opposed to enhancing backscattering). Gold nanocages are a relatively 
new class of structured nanoparticles [3]. Compared to most other nanoparticle contrast 
agents, gold nanocages have a much larger total optical extinction cross section (i.e., the sum 
of scattering and absorption) in the near infrared (NIR) region while maintaining a relatively 
small size (i.e. 80 nm or less). Furthermore, the optical properties of gold nanocages can be 
tailored by modulating the nanostructure geometric parameters including size, wall thickness 
and wall porosity. 
A critical step in the development of any OCT contrast agents is the assessment of the 
optical properties of the agents. Ideally the characterization process should be simple and 
quick yet accurate so that synthesis conditions could be retuned in order to optimize the 
optical properties of the contrast agents (e.g., with stronger scattering than absorption and a 
larger backscattering cross section, etc.). Typically the method of choice is the integrating 
sphere method, which has been used for quantitatively characterizing optical properties of 
scattering samples [9]; however, the results are sensitive to many experimental parameters and 
can often have large fluctuations. Thus a new and easy-to-use method is needed for rapid 
characterization of the contrast agents. Characterization of optical properties using an OCT 
system has been investigated [10–12]. However, the effect of a focused incident beam in a 
scattering sample has not been carefully considered or eliminated in those models, which 
would reduce the accuracy of measurement results. 
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In this paper, we report a new generic method for quickly and accurately characterizing 
the optical properties of OCT contrast agents, including the total extinction, scattering, 
absorption and backscattering cross sections, by using an OCT system itself. The feasibility of 
the new method was validated by comparing the characterization results with both the 
theoretical calculations (i.e., Mie theory for spherical particles [13] and discrete dipole 
approximation (DDA) for non-spherical ones [14]) and the traditional integrating sphere 
measurements. With the aid of this new method, we have successfully developed a new class 
of gold nanocages, which, for the first time, offer stronger scattering than absorption at 
wavelengths around 800 nm among gold nanoparticles [15]. As a result, significant contrast 
enhancement was observed in OCT imaging of a mouse tumor model in vivo by the newly 
developed gold nanocages. 
2. Theoretical analysis 
It is well known that the depth-dependent OCT backscattering intensity can be modeled as: 
 ( ) ( ) ( )
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Θ −
= =
′= ∫ ∫   (1) 
where z is the imaging depth, ϕ and θ  are respectively the azimuthal and polar angle in a 
spherical coordinate system, Θ is the half collection cone angle of the objective lens in the 
sample arm (and 1sin [ ]NA−Θ = , NA is the numerical aperture of the imaging objective lens), 
( )µ θ′ is the angular dependent differential scattering coefficient, extµ  is the total extinction 
coefficient, 1K is a system constant which depends on the detection system (such as the 
incident power and photo detector gain etc.), and ( )h z  is the geometric factor function 
describing both the focusing and scattering effects on the imaging beam in a turbid medium as 
described in [2,16]. Considering the scattering is azimuthally symmetric in highly scattering 
samples and the NA of the imaging lens in most OCT systems is small (i.e. around 0.1 or even 
smaller), the equation can be reduced to [2,16,17]: 
 ( ) ( ) ( )1 sin ,2
ext extz z
bs bsi z K e h z K e h z
µ µµ µ− −Θ= =   (2) 
where bsµ  is backscattering coefficient and 1 sin 2
K K Θ=  is a new system constant. We notice 
that there are three unknowns (i.e. K , bsµ , extµ ) and one function (i.e. ( )h z ) in Eq. (2). 
Extracting the unknowns, particularly those in a multiplicative form, from this equation by 
multi-parameter fitting generally yields very large errors and is not always feasible. 
In order to overcome the challenges involved with direct curve fitting, the basic principle 
is to introduce one type of scattering nanoparticles, of which the optical properties (i.e. 
scattering, absorption, and backscattering cross-sections or coefficients) can be conveniently 
calculated (e.g. using Mie theory or DDA). Two identical samples (phantoms) made of the 
given nanoparticles (e.g. silica nanospheres) with a known concentration are first prepared. 
The test nanoparticles (i.e. gold nanocages in our case) are then added to one of the phantoms 
(named test phantom), while the other phantom serves as the reference phantom. OCT 
imaging is then performed over the test and reference phantoms under the same experimental 
conditions (i.e., with the same incident power, focused spot size, focusing depth, etc.). The 
corresponding OCT signals are: 
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Here ( )ref refbs extµ µ  and ( )test testbs extµ µ are the backscattering (and extinction) coefficients of 
reference and test phantoms, respectively; ( )refh z  and ( )testh z  are the geometric factor 
functions in the reference and test phantom, respectively. If the scattering properties between 
reference and test phantoms do not differ dramatically (e.g., within an order of magnitude), it 
can be reasonably assumed (as confirmed experimentally in this paper) that the difference in 
the geometric factor function between the test and reference phantoms is negligible, i.e., 
( ) ( )ref testh z h z≈ . Therefore, by subtracting the logarithm of the two OCT signals in Eq. (3), 
we cancel out both the system constant and the geometric factor function and obtain the 
following depth-dependent cross-referencing function: 




test ref ext ref
bs
i z i z z µµ
µ
− = − + +   (4) 
Linear fitting can then be applied to Eq. (4) with respect to the imaging depth z, the slope of 
which gives the total extinction coefficient testextµ  of the test phantom. In addition, we will also 
obtain the y-intercept of the Eq. (4) (at z = 0) from the linear fitting, denoted 
as ( )1 ln 12
test ref
bs bsb µ µ= + . Since the backscattering coefficient of the reference phantom 
ref
bsµ can be precisely calculated by the scattering theory (or experimentally measured), the 
backscattering coefficient of the test sample testbsµ can then be easily found, i.e. 
 ( )2 1 .test b refbs bseµ µ= − ⋅   (5) 
The next parameter to consider is the total scattering coefficient scaµ of test nanoparticles, 
which can be deduced from the backscattering coefficient bsµ of the test nanoparticles using 
bs scakµ µ= ⋅ , where k  can be derived by the scattering theory for nanoparticles of a given 
size and shape (and by averaging over the nanoparticle orientations if the nanoparticle does 
not have a spherical shape). The absorption coefficient of the test nanoparticles is then given 
by test test testabs ext scaµ µ µ= − . This algorithm is fast and only involves OCT measurements. The above 
linear fitting procedure is very robust compared to the multivariable curve fitting procedure. 
More importantly, the new algorithm can provide a whole set of optical properties of the 




absµ  and 
test
bsµ . 
3. Algorithm verification 
Before applying the above characterization algorithm to gold nanocages, we performed an 
experiment to verify it on mock nanoparticles. In this experiment, we used home synthesized 
silica nanospheres of a 180 20± nm diameter as the reference nanoparticles. The reference 
and test phantoms were made of 5% gelatin embedded with 50 and 100 mg/mL silica 
nanospheres, respectively. Therefore, the test and the reference nanoparticles are both at a 
concentration of 50 mg/mL in the 5% gelatin phantom. The optical properties, including the 
scattering (no absorption) and backscattering cross sections, of the fused silica nanosphere at 
the given concentration in the medium can be analytically predicted by the Mie scattering 
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theory, and the angular dependent scattering pattern as shown in Fig. 1(A). OCT imaging was 
conducted using a 7-fs Ti:Sapphire laser as the light source with a center wavelength at 825 
nm and a 3dB spectral bandwidth of ~150 nm. The NA of the imaging lens in the sample arm 
was about 0.1 and the averaged power on the sample arm was ~4 mW. OCT images of the two 
phantoms were acquired by scanning an imaging beam across the two side-by-side phantoms 
under the same experimental conditions. 
 
Fig. 1. (A) Angular dependent scattering pattern of 180 nm silica nanospheres in a 5% gelatin 
phantom at the wavelength of 825 nm calculated by the Mie scattering theory. (B) Angular 
dependent scattering pattern of 75 nm gold nanocages in a 5% gelatin phantom at the 
wavelength of 825 nm calculated by a numerical method based on discrete dipole 
approximation (DDA). The scattering pattern is averaged over various nanoparticle 
orientations. 
After OCT imaging of both phantoms, A-scan OCT intensity signals were obtained as a 
function of imaging depth by averaging along the B-scan direction in order to remove 
heterogeneity of the phantom samples and reduce the speckle noise. The first step is to extract 
the total extinction and back scattering coefficients from the averaged A-line signals (e.g., 
averaged over 500 A-lines). By applying the aforementioned algorithm to the test and 
reference A-scan OCT intensity signals, the extinction coefficient of test silica nanospheres 
was extracted in the test phantom (at a mass concentration of 50 mg/mL) as 
-10.640 mmtestextµ = . To deduce the extinction cross section of a single fused silica nanosphere, 
we first need find out the molar concentration of the silica nanospsheres in the test phantom 
by converting the mass concentration to the molar concentration. And the molar concentration 
was found to be 9.88 nM=testc . The extinction cross section of a fused silica nanosphere is 
then given by 16 21.08 10  mtesttestext ext AN cσ µ
−= = ×  (where AN  is Avogadro constant). This 
extinction cross section is very close to the theoretical value 16 21.16 10  mMieextσ
−= ×  predicted 
by the Mie theory. The ratio of the backscattering coefficients of the test to the reference 
nanoparticles denoted by test refbs bsµ µ  can be found from Eq. (5), and the resulted value is 0.96 
which is very close to the theoretical limit of 1 in this case (considering test and reference 
silica nanospheres had the same concentration in this experiment). We notice that the 
accuracy of the algorithm in determining the extinction coefficient and the backscattering 
ratio of the test and the reference nanoparticles is excellent; warranting that neglecting the 
geometric factor function ( )h z  in Eq. (4) is safe. 
The next step is to separate the total scattering and absorption coefficient of the test silica 
nanospheres from the total extinction coefficient. Since the backscattering coefficient of 
reference silica nanospheres was calculated by the Mie theory as -10.695 mmrefbsµ = , we were 
able to deduce the backscattering coefficient of test silica nanospheres to be 
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-10.667 mmtestbsµ = (from Eq. (5)). From the scattering pattern predicted by the Mie theory (as 
shown in Fig. 1(A)), the ratio of the total scattering to the backscattering coefficient 
is 1.008=k . Therefore, the total scattering coefficient of test silica nanospheres 
is -1/ 0.661 mmtest testsca bs kµ µ= = , and the absorption coefficient of the test silica phantom is 
-10.0214 mmtest test testabs t scaµ µ µ= − = − (which, in theory, should be zero). It is noted that the relative 
errors in the extinction coefficient between the experimental measurements and theoretical 
predictions are within 7%, demonstrating the feasibility of the proposed cross-referencing 
method for optical properties characterization. 
Similar experiments of different concentrations of fused silica nanospheres were repeated 
three times and all results showed that the relative measurement errors (i.e. the variation in the 
characterization results) in the extinction and backscattering cross sections were no more than 
3% among experiments, confirming the robustness of this method for optical properties 
characterization. 
4. Experimental results 
4.1 Characterization of optical properties of gold nanocages 
After verifying the accuracy of the algorithm, we used it to fully characterize the optical 
properties of the newly developed gold nanocages, aiming to provide quick feedback to 
optimize nanocage synthesis conditions for achieving scattering dominating optical properties 
and thus OCT imaging contrast enhancement with the nanocages. Similar to the above 
feasibility experiments, two identical phantoms were made by embedding 50 mg/mL silica 
nanospheres into 5% gelatin, whose optical properties again can be calculated using the Mie 
theory. Gold nanocages were added to one of the phantoms at a nominal concentration of 1.0 
nM. OCT imaging of the test (with nanocages) and reference (without nanocages) phantoms 
was performed under the same conditions as mentioned in the previous section. 
Figure 2(A) shows the OCT images of the reference phantom (on the left) and the test 
phantom (on the right), respectively, and the decay curves of the OCT intensity along imaging 
depth in both cases are given in Fig. 2(B). Using the cross-referencing method, the extinction 
coefficient and the backscattering coefficient of gold nanocages in the test phantom were 
calculated from the slope and y-intercept of Eq. (4), and the resulted values are 
-11.71 mmAuextµ =  and 
-11.34 mmAubsµ = , where the backscattering coefficient 
-10.695 mmrefbsµ = of the reference nanoparticles (silica nanospheres) predicted by Mie theory 
was used for Eq. (5). Figure 2(C) shows the ratio of the two depth-dependent signals shown in 
Fig. 2(B), and the nearly perfect linear relationship of this ration versus imaging depth also 
implies that the potential difference in ( )h z  of the test and reference phantoms can be safely 
neglected. To calculate the scattering coefficient of the nanocages from the backscattering 
coefficient, we need first to find the relationship constant k in Au Aubs t scakµ µ= ⋅ . A numerical 
simulation method based on DDA was used to calculate the orientation averaged, angular 
dependent scattering pattern and the result is shown in Fig. 1(B), from which the parameter tk  
is found to be 1.385. The scattering coefficient of nanocages is then given 
by -1/ 0.967 mmAu Ausca bs tkµ µ= = . The absorption coefficient is thus 
10.743 mmAu Au Auabs ext scaµ µ µ
−= − = . We notice that the ratio of the scattering to the absorption 
coefficient is about 1.31, showing the scattering dominance in the optical extinction 
coefficient. To independently validate the optical properties obtained from OCT phantom 
imaging, integrating sphere experiments were performed to directly measure the optical 
properties of the nanocages, where the ratio of scattering to absorption coefficient was found 
to be ~1.27 at the central wavelength (825 nm) of the OCT source, and this ratio was very 
close to the one obtained by cross-referencing OCT method. Taking into account the 
nanocage concentration (1 nM), the corresponding cross sections of a gold nanocage can be 
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found as 15 22.84 10  mextσ
−= × , 15 21.61 10  mscaσ
−= × , 15 21.23 10  mabsσ
−= ×  and 
15 22.23 10  mbsσ
−= × . It is noted that the measured cross sections differ from the ones 
predicted by DDA simulations (i.e. 15 23.30 10  mDDAscaσ
−= ×  and 15 21.95 10  mDDAabsσ
−= × ). One 
major reason accounting for this discrepancy is the potential loss of gold nanocages during 
sample preparation which was inevitable; thus the actual concentration could be lower than 
the nominal one, underestimating the overall cross section values. 
 
Fig. 2. (A) OCT images of the phantoms without nanocages (left) and with nanocages (right). 
(B) Intensity plots of the OCT signals on a linear scale as a function of imaging depth. (C) 
Ratio of the two signals in (B) on a logarithmic scale as a function of imaging depth. 
4.2 Contrast enhancement of gold nanocages for OCT imaging of tumor in vivo 
We examined the feasibility of using the very first scattering-dominant gold nanocages as a 
contrast agent for in vivo OCT imaging of tumor on a xenograft mouse model. Three male 
Balb/c nude mice, 6–8 weeks of age and about 25 g of average weight, were obtained from the 
Taconic Farmer (One Hudson City Centre, Hudson). Approximately 65 10×  human 
epidermoid carcinoma cells (A-431) suspended in 50 µL PBS were injected subcutaneously 
into the ear of the mice and the ear tumors developed on two of the three mice. 10 days after 
tumor cell inoculation, OCT imaging of the mouse tumor on the ear was performed before and 
after 4 fractionated tail vein injections (24 hours apart) of PEGylated gold nanocages (150μL 
of 1nM solution per injection). The animal experimental procedures in this study were 
approved by the Institutional Animal Care and Use Committee at the Johns Hopkins 
University. 
Figures 3(A) and 3(B) show a representative OCT image of the tumor before and after the 
administration of gold nanocages, respectively, and the corresponding decay curves on a 
logarithm scale are shown in Fig. 3(C). It is evident that the presence of gold nanocages 
increases the backscattering in the tumor, thus enhancing OCT imaging contrast. More 
interestingly, fine structures were able to be observed after the injection of gold nanocages (as 
shown in Fig. 3(B)). It is noted that the contrast enhancement is approximately ~2.4 dB on 
average, and to the best of our knowledge, this is the highest OCT contrast enhancement by 
nanoparticles of a similar size and at a similar concentration. The contrast enhancement (in 
dB) and its moving average versus imaging depth are shown in Fig. 3(D), which suggest that 
the accumulation of the gold nanocages started ~70 µm below the epidermis (where the tumor 
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boundary is supposed to be as indicated by the arrows in Figs. 3(A), 3(B) and 3(D)) and 
reached its peak around 300 µm beneath the surface. 
 
Fig. 3. (A) In vivo OCT images of a mouse ear tumor (induced with A431 cell line) before (A) 
and after (B) intravenous injection of gold nanocages, respectively. (C) Depth-dependent OCT 
intensity plots from the tumor on a logarithm scale before (blue curve) and after (red curve) the 
administration of gold nanocages. (D) The ratio of the two curves in (C) and its moving-
average results on a logarithm scale. 
5. Discussion 
Several issues need to be considered in order to use the cross-referencing method properly. 
Firstly, in order to linearly fit the difference curve represented by Eq. (4), the A-scan OCT 
intensity signals from the reference and the test phantom need to be significantly above the 
noise floor of the OCT system. An alternative is to choose a segment from the entire depth 
profile of the OCT intensity. 
Secondly, although the method was initially developed for an imaging system with a small 
NA as discussed in the Algorithm session, it should be applicable, in principle, to a large NA 
imaging system as well. Instead of using a single backscattering coefficient at 180°, a definite 
integral of the differential scattering coefficient over the entire collection angle (NA) should 
be used to get a new parameter k that relates the total scattering coefficient to the 
backscattering coefficient. 
Thirdly, the cross-referencing method assumes an approximation that the difference in the 
geometric factor function ( )h z  in the test and reference phantom is negligible. In addition to 
the depth-dependent transparent-medium-equivalent point-spread function [18], ( )h z  also 
takes into account the scattering effect on the point-spread function in a turbid medium [16]. 
In theory, ( )h z  would change as the scattering property changes and thus the two ( )h z ’s 
would not perfectly cancel out each other in the two A-scan signals (from Eq. (3) to Eq. (4)). 
However, from what we experimentally observed (see Section 3), the change in ( )h z  was 
negligible even the scattering coefficient changed by about 2 mm−1 from the reference to test 
phantom. When using gold nanocages for enhancing OCT imaging contrast, the concentration 
of the gold nanocages in tissue would be on the order of nM or less considering the small 
systemic injection volume (100-200 uL) and low concentration (1 nM). The resulted change 
in scattering coefficient would thus be small (e.g. -11.0 mmAuscaµ < ) compared to the scattering 
coefficient of highly scattering biological tissues (i.e. -110 mmtissuscaµ ≈  [19]). Hence it is safe 
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to neglect the change in ( )h z  before and after the administration of gold nanocages and 
consequently the cross-referencing characterization method (Eq. (4)) is applicable. 
Moreover, the cross-referencing method (Eq. (4)) also enables semi-quantitative analysis 
of the OCT contrast enhancement when using contrast agents and thus can provide a general 
guideline on choosing the optimal concentration and optical properties for nanoparticle-based 
contrast agents. We notice that there are two competing effects generated by the contrast 
agents in biological tissue: contrast enhancement (by the backscattering coefficient) and 
intensity attenuation (by the total extinction coefficient). Here we propose a simple model for 
semi-quantitatively analyzing the balance between these two effects in order to gain a 
maximal contrast enhancement. By comparing the OCT intensity signal before and after the 
administration of contrast agents, we have: 




after before ext tissue
bs
i z i z z µµ
µ
 
− = − + + 
 
  (6) 
where CAextµ and
CA
bsµ  are respectively the extinction and backscattering coefficient of the 
contrast agent, and tissuebsµ is the backscattering coefficient of tissue. Substituting 
CA CA
ext ext A CAN Cµ σ= ⋅ ⋅ and 
CA CA
bs scakµ µ= ⋅ into Eq. (7) where C and 
CA
extσ are the molar 
concentration and extinction cross section of a given contrast agent, respectively, and AN is 
the Avogadro constant, we have the following equation: 
 





ext A Au tissue
bsbefore





  ⋅ ⋅ ⋅  + = − ⋅ ⋅ ⋅ + + 
      
  (7) 
where sca absr µ µ=  is the ratio of the scattering to absorption coefficient for the contrast 
agent and k  is the ratio of backscattering to total scattering coefficient of the contrast agent. 
In order to observe contrast enhancement in tissue, Eq. (7) has to be greater than unity. To 
perform numerical calculations, we first need to estimate the backscattering coefficient. For 
most tissues in the NIR region, the backscattering coefficient varies from 0.1 to -11.0 mm  
[20]. And we choose the backscattering coefficient to be -10.1 mm  here. For the gold 
nanocages, we have 1.31sca absr µ µ= =  and 
15 22.84 10  mAuextσ
−= × . With these parameters, 
the contrast enhancement curves versus contrast agent concentration at different imaging 
depths were calculated using Eq. (7) and the results are shown in Fig. 4. We find that all the 
curves start from unity when the concentration is very low (i.e., 1 pM), and the contrast 
enhancement increases slowly as the concentration of agents increases. When the 
concentration continues increasing, the contrast enhancement curves at different depths begin 
to deviate from each other and the contrast starts decreasing versus concentration owing to the 
increase in the extinction coefficient (and thus signal attenuation) by the contrast agent. As 
seen in Fig. 4, most of the curves reach their peaks when the concentration is around 0.3-0.4 
nM. The peak of contrast enhancement curves decreases as the imaging depth increases, from 
>3 fold at 100 µm to <1.5 fold at 800 µm. When contrast agent concentration keeps 
increasing, the contrast enhancement is compromised and eventually it will drop below unity 
(i.e. negative contrast). 
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Fig. 4. The estimation of contrast enhancement with respect to the concentration of OCT 
contrast agent at different imaging depths. 
Equation (7) also shows that better contrast enhancement can be achieved by increasing 
the parameter  (= / )CA CAbs scak µ µ and ( / )
CA CA
sca absr µ µ= , suggesting the benefit of having a scattering 
dominating contrast agent (i.e. a large parameter r) and an agent with a large backscattering 
cross section. For gold nanocages, the overall cross sections of gold nanocages are at least one 
order of magnitude higher than other OCT contrast agents at the same size due to the unique 
structure of nanocages [21]. In other words, only a smaller size is needed with gold nanocages 
compared to other contrast agents for the same cross sections. The small size of gold 
nanocages in fact leads to a larger ratio k of the backscattering to the total scattering cross 
section, which is beneficial for OCT contrast enhancement. Furthermore, our newly 
synthesized gold nanocages are scattering dominant (r>1), which further helps improve the 
backscattered OCT signal. 
6. Conclusion 
In summary, we developed a generic cross-referencing method to offer accurate, quick and 
full characterization of the optical properties of nanoparticles as an OCT contrast agent by 
using a standard OCT system alone. The accuracy of the method was confirmed by phantom 
experiments using fused silica nanospheres and predictions by the Mie theory. With the aid of 
this method, synthesis conditions of gold nanocages were fine-tuned, resulting in scattering 
dominance in the optical properties for the first time with the ratio of scattering over 
absorption of about 1.31sca absσ σ = , which was consistent with the results from the 
integrating sphere measurements. In vivo animal tumor model imaging with systemic 
administration of the gold nanocages was also performed, demonstrating significant contrast 
enhancement (i.e. by ~2.4 dB). This generic optical properties characterization method can be, 
in principle, applied to any other nanoparticle based OCT contrast agents. The same principle 
can also be used in in vivo tissue imaging to provide a semi-quantitative guideline for 
choosing a proper concentration of a given contrast agent in order to achieve optimal contrast 
enhancement. 
Acknowledgments 
The authors would like to thank Du Le and Dr. Jessica Ramella-Roman at the Department of 
Biomedical Engineering, Catholic University of America for helping perform the integrating 
sphere measurements of the gold nanocages. The authors would also like to acknowledge the 
funding support from the National Institutes of Health (NIH) (R01EB007636). Publication of 
this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins 
University Libraries. 
#187785 - $15.00 USD Received 26 Mar 2013; revised 6 May 2013; accepted 7 May 2013; published 9 May 2013
(C) 2013 OSA 1 June 2013 | Vol. 4,  No. 6 | DOI:10.1364/BOE.4.000842 | BIOMEDICAL OPTICS EXPRESS  851
